Development of a decision flowchart to identify the patients need high-dose vancomycin in early phase of treatment.

Ryo YamaguchiHiroko KaniTakehito YamamotoTakehiro TanakaHiroshi Suzuki

Published in: Journal of pharmaceutical health care and sciences (2022)

These results suggest that the decision flowchart constructed in this study provides an important contribution for avoiding underdosing of VCM in patients with eCCr of ≥50 mL/min.

Keyphrases

high dose
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
low dose
decision making
peritoneal dialysis
prognostic factors
patient reported